title: Invited commentary on … Lithium treatment and risk for dementia in adults with bipolar disorder.
abstract: Alzheimer's disease clinical trials are failing at an alarming rate, highlighting the desperate need for novel thinking to combat this escalating health crisis. A recent large-scale population study indicates that lithium treatment reduces dementia development, supporting preclinical mechanistic evidence that this commonly used agent might be clinically valuable in dementia.
authors.affiliation: Calum Sutherland, BSc, PhD, Division of Cardiovascular and Diabetes Medicine, Ninewells Medical School, Dundee, Scotland; Ashleigh C. Duthie, MRCPsych, MSc, Susan Carnegie Centre, Stracathro Hospital, near Brechin, Scotland c.d.sutherland@dundee.ac.uk.
authors.forename: Calum
authors.initials: C
authors.lastname: Sutherland
authors.affiliation: Calum Sutherland, BSc, PhD, Division of Cardiovascular and Diabetes Medicine, Ninewells Medical School, Dundee, Scotland; Ashleigh C. Duthie, MRCPsych, MSc, Susan Carnegie Centre, Stracathro Hospital, near Brechin, Scotland.
authors.forename: Ashleigh C
authors.initials: AC
authors.lastname: Duthie
mesh_terms: D018692:Antimanic Agents / Q000008:administration & dosage*; D001714:Bipolar Disorder / Q000188:drug therapy*; D003704:Dementia / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008094:Lithium / Q000008:administration & dosage*; D008297:Male
chemical_list: D018692:Antimanic Agents; D008094:Lithium